MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion

AUSTIN, Texas — MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today announced that it has entered into a binding commitment with Sanabil (Cayman) for a senior unsecured revolving credit facility of up to US$30 million. The facility is intended to support MindWalk’s biologics programs, commercial expansion, working capital, and general corporate purposes.

The facility carries a fixed annual interest rate of 7.00%, accruing only on amounts drawn, and an initial term of 36 months, extendable by 12 months by agreement. It includes no financial maintenance covenants, warrants, or equity conversion feature and requires no pledge of MindWalk assets. There is no material adverse change condition to closing. MindWalk has no obligation to borrow and may repay amounts drawn without penalty. A one-time 1.00% opening fee applies, with no unused line fee. The term sheet is binding on both parties. MindWalk and Sanabil (Cayman) will negotiate a definitive credit agreement consistent with its terms, with a target closing within 60 days, and MindWalk expects to file the agreement as a material contract exhibit.

A welcome email is on its way. If you don't see it, please check your junk folder.

“This facility funds our biologics programs and our commercial build without issuing a single share,” said Jennifer Bath, PhD, President and Chief Executive Officer of MindWalk. “We chose debt over equity for a simple reason. We were not prepared to raise capital of this size in equity at the current share price, and we did not have to. Sanabil took no warrants, no conversion feature, and no security over any asset we own, so the full benefit of executing our plan stays with the shareholders who own it today.”

Sanabil (Cayman) is a private investment and structured finance firm based in George Town, Grand Cayman, Cayman Islands.

MindWalk Holdings Corp. (NASDAQ: HYFT) is a Bio-Native AI company building the BioIntelligence infrastructure that life sciences AI and agentic AI require, integrating AI, data, and advanced wet lab capabilities into one connected discovery ecosystem. At its core is HYFT ® Technology, a proprietary, function-aware representation of biology. Its HYFT pattern-objects span sequence and structural biology and, refined over 20 years of curation, form a continuously evolving biological representation of 660 million patterns and 25 billion relationships. This enriched biological representation is the architecture behind ReefIQ™, the biological data substrate that provides context for life sciences, enriching data at ingestion and growing more valuable with each program run on it, and LensAI™, the reasoning and application layer for target discovery, candidate diligence, portfolio decision support, and the agentic AI workflows pharmaceutical companies are now deploying. By design, value compounds in this HYFT representation layer, not in any individual AI model that runs on top of it.

This press release contains forward-looking statements within the meaning of applicable United States and Canadian securities laws.